LifeStance Health Group Financial Statements (LFST)
|
|
|
|
Report date
|
|
|
17.03.2022 |
09.03.2023 |
28.02.2024 |
27.02.2025 |
25.02.2026 |
|
07.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
667.5 |
859.5 |
1 056 |
1 251 |
1 424 |
|
1 495 |
|
Operating Income, bln rub |
|
|
-286.4 |
-210.2 |
-189.1 |
-31.6 |
25.7 |
|
45.3 |
|
EBITDA, bln rub |
? |
|
-240.1 |
-143.6 |
-104.9 |
39.9 |
78.8 |
|
99.1 |
|
Net profit, bln rub |
? |
|
-307.2 |
-215.6 |
-186.3 |
-57.4 |
9.66 |
|
23.2 |
|
|
OCF, bln rub |
? |
|
9.42 |
52.8 |
-16.9 |
107.3 |
146.2 |
|
182.4 |
|
CAPEX, bln rub |
? |
|
94.5 |
79.3 |
40.5 |
21.6 |
36.1 |
|
54.0 |
|
FCF, bln rub |
? |
|
-85.1 |
-26.5 |
-57.4 |
85.7 |
110.0 |
|
178.8 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
|
|
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
|
OPEX, bln rub |
|
|
487.9 |
447.2 |
491.2 |
434.0 |
380.6 |
|
401.2 |
|
Cost of production, bln rub |
|
|
466.0 |
622.5 |
753.6 |
848.6 |
1 018 |
|
1 048 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
38.9 |
19.9 |
21.2 |
26.5 |
11.7 |
|
10.4 |
|
|
Assets, bln rub |
|
|
1 927 |
2 174 |
2 110 |
2 118 |
2 204 |
|
2 146 |
|
Net Assets, bln rub |
? |
|
1 545 |
1 519 |
1 429 |
1 446 |
1 521 |
|
1 477 |
|
Debt, bln rub |
|
|
158.7 |
478.8 |
511.0 |
485.2 |
194.1 |
|
196.2 |
|
Cash, bln rub |
|
|
148.0 |
108.6 |
78.8 |
154.6 |
248.6 |
|
194.8 |
|
Net debt, bln rub |
|
|
10.7 |
370.2 |
432.2 |
330.6 |
-54.5 |
|
1.39 |
|
|
Ordinary share price, rub |
|
|
9.52 |
|
|
7.37 |
7.04 |
|
6.37 |
|
Number of ordinary shares, mln |
|
|
327.5 |
355.3 |
367.5 |
379.1 |
386.0 |
|
387.3 |
|
|
Market cap, bln rub |
|
|
3 118 |
0 |
0 |
2 794 |
2 718 |
|
2 467 |
|
EV, bln rub |
? |
|
3 129 |
370 |
432 |
3 125 |
2 663 |
|
2 468 |
|
Book value, bln rub |
|
|
40 |
-18 |
-85 |
-38 |
50 |
|
5 |
|
|
EPS, rub |
? |
|
-0.94 |
-0.61 |
-0.51 |
-0.15 |
0.03 |
|
0.06 |
|
FCF/share, rub |
|
|
-0.26 |
-0.07 |
-0.16 |
0.23 |
0.29 |
|
0.46 |
|
BV/share, rub |
|
|
0.12 |
-0.05 |
-0.23 |
-0.10 |
0.13 |
|
0.01 |
|
|
EBITDA margin, % |
? |
|
-36.0% |
-16.7% |
-9.94% |
3.19% |
5.53% |
|
6.63% |
|
Net margin, % |
? |
|
-46.0% |
-25.1% |
-17.6% |
-4.59% |
0.68% |
|
1.55% |
|
FCF yield, % |
? |
|
-2.73% |
|
|
3.07% |
4.05% |
|
7.25% |
|
ROE, % |
? |
|
-19.9% |
-14.2% |
-13.0% |
-3.97% |
0.64% |
|
1.57% |
|
ROA, % |
? |
|
-15.9% |
-9.92% |
-8.83% |
-2.71% |
0.44% |
|
1.08% |
|
|
P/E |
? |
|
-10.1 |
0.00 |
0.00 |
-48.6 |
281.2 |
|
106.3 |
|
P/FCF |
|
|
-36.7 |
0.00 |
0.00 |
32.6 |
24.7 |
|
13.8 |
|
P/S |
? |
|
4.67 |
0.00 |
0.00 |
2.23 |
1.91 |
|
1.65 |
|
P/BV |
? |
|
77.7 |
0.00 |
0.00 |
-73.8 |
54.3 |
|
467.6 |
|
EV/EBITDA |
? |
|
-13.0 |
-2.58 |
-4.12 |
78.4 |
33.8 |
|
24.9 |
|
Debt/EBITDA |
|
|
-0.04 |
-2.58 |
-4.12 |
8.29 |
-0.69 |
|
0.01 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
|
CAPEX/Revenue, % |
|
|
14.2% |
9.22% |
3.84% |
1.72% |
2.54% |
|
3.61% |
|
| LifeStance Health Group shareholders |
